Gateway 2012: Gemü Valves - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2012: Gemü Valves


Gemü Valves
3800 Camp Creek Parkway
Bldg 2600 Ste 120
Atlanta, GA 30331
www.gemu.com
info@gemu.com
Telephone: 678-553-3400
Fax: 404-344-4003

Company Description:

Gemü Valves, an ISO9001 certified company, is a leading world-wide manufacturer of high quality valves, measurement and controls systems. The Gemü product line includes Diaphragm, Globe, Angle Seat and PFA, PVDF and Polypropylene valves, as well as, Measurement and Control Systems. With an unparalleled vision of excellent customer service, Gemü serves the Pharmaceutical, Microelectronics, Semiconductor, Food and Beverage, Chemical, Mining and Metal Extraction, and Water/Waste Water Treatment Industries. Gemü’s ground breaking design and leading edge manufacturing technology provides engineered solutions to complex process challenges. Gemü’s overriding philosophy is to ensure that each and every customer contact is a quality experience.

Stop by booth 3612 at Interphex New York to see Gemü’s products. The 4242 Combi Switchbox offers unprecedented reliability and repeatability and features a highly visible glowtop indicator and local and remote programming along with local and remote diagnostics.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here